IQVIA Holdings Inc. reported first-quarter 2025 revenue of $3,829 million, an increase of 2.5% on a reported basis and 3.5% at constant currency compared to the prior year. This performance exceeded Wall Street expectations, driven by strong demand in its Technology & Analytics Solutions (TAS) segment.
The TAS segment's revenue grew by 6.4% reported and 7.6% at constant currency to $1,546 million, demonstrating robust performance. The Research & Development Solutions (R&DS) segment saw a modest increase of 0.3% reported and 1.1% at constant currency to $2,102 million, despite delayed customer decision-making.
Adjusted diluted EPS for Q1 was $2.70, up 6.3% year-over-year, and adjusted EBITDA increased by 2.4% to $883 million. The R&DS contracted backlog reached $31.5 billion, growing 4.8% year-over-year, with $7.9 billion expected to convert to revenue in the next twelve months.
IQVIA raised its full-year 2025 revenue guidance to between $16,000 million and $16,400 million, primarily due to more favorable foreign currency exchange rates. The company reaffirmed its profit guidance for adjusted EBITDA and adjusted diluted EPS, signaling confidence in its operational execution.
During the first quarter, IQVIA repurchased $425 million of its common stock, with $2,588 million of share repurchase authorization remaining. This reflects the company's commitment to returning value to shareholders amidst market conditions.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.